MCAT topics → Integrative Organ Systems → Skeletal System (Bone Structure, Calcium Homeostasis)

Skeletal System (Bone Structure, Calcium Homeostasis)

MCAT trap: Assumes PTH uniformly builds bone, missing its primary role in raising serum calcium via bone resorption. Continuous high PTH stimulates osteoclast-mediated bone resorption and raises serum Ca2+; only intermittent PTH exposure has anabolic (bone-building) effects.

Bone physiology is tested heavily on the MCAT — and the most common hormonal misconception is about vitamin D. Vitamin D's primary action is in the gut, not in bone directly. Calcitriol upregulates calcium-binding proteins in intestinal enterocytes, increasing how much dietary calcium enters the bloodstream. Without adequate vitamin D, you can eat plenty of calcium and still develop rickets — the calcium never makes it into systemic circulation in sufficient amounts to mineralize bone. You need to know both the structural anatomy (compact vs. spongy bone, bone cell types, marrow) and the hormonal regulation of calcium, because the exam combines them in passages about hyperparathyroidism, vitamin D deficiency, and bisphosphonate therapy.

The MCAT hits this topic from three angles: pure recall (what do osteoblasts do?), mechanism (how does PTH raise serum calcium?), and passage interpretation (a graph shows rising PTH — what happens to bone density over time?). The mechanism questions are where students lose points, especially anything involving the dose-dependent or exposure-pattern-dependent effects of PTH. The exam loves to present a scenario that seems straightforward but actually requires you to distinguish between acute vs. chronic hormonal effects.

The biggest traps here are role-swapping (osteoblasts vs. osteoclasts) and inverting hormone effects (calcitonin vs. PTH on osteoclasts). These aren't random errors — they reflect genuinely confusing relationships that the test writers know students memorize incorrectly. If you've been treating vitamin D as something that 'puts calcium in bone,' you have the mechanism backwards, and that error will cost you on questions about malabsorption syndromes or rickets. Lock in the mechanisms, not just the outcomes.

Common misconceptions

Common mistake
Wrong: PTH always increases bone density by stimulating osteoblast activity.
Right: Continuous high PTH stimulates osteoclast-mediated bone resorption and raises serum Ca2+; only intermittent PTH exposure has anabolic (bone-building) effects.
PTH's effect on bone depends entirely on how it's delivered. Chronically elevated PTH — as seen in hyperparathyroidism — preferentially activates osteoclasts, leading to net bone resorption and elevated serum calcium. Intermittent, pulsatile PTH actually favors osteoblast activity and is the basis for teriparatide, an osteoporosis drug. When you see PTH on the MCAT, ask yourself: is this a sustained elevation or a brief pulse? The default clinical scenario (hyperparathyroidism, chronic renal failure) almost always means bone loss, not bone gain.
Common mistake
Wrong: Calcitonin raises serum calcium by stimulating osteoclasts, opposing PTH.
Right: Calcitonin lowers serum calcium by inhibiting osteoclast activity; it opposes PTH's calcium-raising effect.
Calcitonin is released from thyroid C-cells when serum calcium is high, and its job is to bring that calcium back down — it inhibits osteoclasts, reducing bone resorption. This is the direct opposite of PTH. A useful mental anchor: calcitonin 'calms' osteoclasts and lowers calcium; PTH activates osteoclasts and raises calcium. Mixing these up inverts the entire calcium homeostasis picture, so nail this relationship cold.
Common mistake
Wrong: Osteoclasts deposit new bone matrix and osteoblasts resorb old bone.
Right: Osteoblasts synthesize and deposit bone matrix; osteoclasts resorb bone by secreting acid and proteases.
The 'blast' vs. 'clast' distinction is exactly what it sounds like: blasts build, clasts break. Osteoblasts are derived from mesenchymal stem cells and lay down osteoid (unmineralized matrix), which then calcifies. Osteoclasts are large, multinucleated cells derived from monocyte/macrophage precursors that dig into bone by secreting hydrochloric acid and cathepsin K to dissolve mineral and protein matrix. If you keep swapping them, anchor it this way: osteoCLASTs are like wrecking crews — they demolish the structure.
Common mistake
Wrong: Vitamin D directly deposits calcium into bone without affecting intestinal absorption.
Right: Active vitamin D (calcitriol) primarily increases intestinal calcium and phosphate absorption, raising serum levels available for bone mineralization.
Vitamin D's primary action is in the gut, not the bone itself. Calcitriol (the active 1,25-dihydroxyvitamin D₃ form) upregulates calcium-binding proteins in intestinal enterocytes, dramatically increasing how much dietary calcium gets absorbed into the bloodstream. It also increases phosphate absorption. More circulating calcium and phosphate then makes mineralization of osteoid possible. Without adequate vitamin D, you can eat plenty of calcium and still develop rickets or osteomalacia — the calcium never makes it into the blood in sufficient amounts to mineralize bone.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Distinguish compact bone (dense, organized osteons, cortical shell) from spongy/trabecular bone (porous, found in epiphyses and flat bones) and recognize how bone shape categories (long, short, flat, irregular) relate to their function and marrow content.
  2. Explain the specific roles of each bone cell type: osteoblasts synthesize and deposit new bone matrix, osteoclasts resorb bone via acid and proteases, and osteocytes are embedded former osteoblasts that sense mechanical load and coordinate remodeling signals.
  3. Trace the hormonal mechanisms controlling serum calcium: PTH raises serum Ca²⁺ by stimulating osteoclast-mediated bone resorption and renal Ca²⁺ reabsorption; calcitonin lowers serum Ca²⁺ by inhibiting osteoclasts; active vitamin D (calcitriol) raises serum Ca²⁺ by increasing intestinal absorption of calcium and phosphate.
  4. Differentiate red marrow (site of hematopoiesis, found in flat bones and epiphyses of long bones in adults) from yellow marrow (fat storage, found in diaphyses of long bones), and know that red marrow can expand into yellow marrow sites under high physiological demand.

Can you avoid these mistakes?

A patient with a parathyroid adenoma has had chronically elevated PTH for two years. Would you expect their bone density to be increased, decreased, or unchanged? What happens to their serum calcium, and which bone cell type is primarily responsible?
Vitamin D deficiency leads to poor bone mineralization despite normal dietary calcium intake. Explain the mechanism — specifically, where in the body does vitamin D exert its primary effect to raise serum calcium, and why does deficiency impair bone even if osteoblasts are functioning normally?
A passage describes a new drug that mimics calcitonin. A patient with hypercalcemia is given this drug. Predict the effect on osteoclast activity and serum calcium levels, and explain how this differs from the mechanism of PTH.
During severe hemorrhagic anemia, the body expands its hematopoietic capacity. Which type of bone marrow is recruited, where does it come from anatomically in an adult, and what does this tell you about the normal marrow distribution in adults vs. children?

Related topics

Thyroid and Parathyroid Hormones Heart Anatomy and Conduction System Cardiac Cycle and Pressure-Volume Relationships Arteries, Veins, Capillaries — Structure and Function Blood Composition (RBC, WBC, Platelets, Plasma)

See how your Anki deck covers this topic.

Upload your deck for a free audit →